跳至主要内容
临床试验/NCT07735338
NCT07735338尚未招募不适用

Prospective Study of the Diagnostic Accuracy of a Smartphone Application to PREDICT Real-Time Cardiovascular Risk for Heart Attack and Stroke (PREDICT-HS)

Stanford University1 个研究点 分布在 1 个国家目标入组 300 人开始时间: 2026年10月1日最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
入组人数
300
试验地点
1
主要终点
Number of ASCVD events

研究概览

简要总结

To assess the diagnostic accuracy of a smartphone application in predicting heart attack or stroke within 3-4 days in high-risk patients.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Other
盲法
None

入排标准

年龄范围
40 Years 至 79 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Be able to provide electronic or written informed consent and be able to effectively communicate and understand the study procedures, risks, and required activities.
  • Age 40 to 79 years.
  • Be willing to wear a smartwatch continuously for 18 months and comfortable with using wearable devices or other technologies that monitor their data over time.
  • Established ASCVD or at an increased risk for a first MACE (i.e., no prior major ASCVD event), defined as anyone of the following:
  • i) Evidence of atherosclerotic CAD on CT or invasive coronary angiogram defined as a coronary artery stenosis ≥ 20% but <50% in the left main coronary artery or a stenosis ≥ 20% but <70% in any other major coronary artery.
  • ii) Coronary artery calcium score ≥ 100 Agatston units.
  • iii) High estimated10-year ASCVD risk ≥ 20% by pooled cohort equation.
  • iv) Intermediate estimated 10-year ASCVD risk 7.5% to <20% by pooled cohort equation with at least 2 of the following risk-enhancing factors:
  • A first degree relative with history of premature ASCVD (males, age <55 years; females, age <65 years).
  • History of premature menopause before age
  • History of maternal pregnancy complications (defined as a history of either preeclampsia, gestational hypertension, or gestational diabetes).
  • South Asian ancestry.
  • Chronic inflammatory disorders (defined as either rheumatoid arthritis, systemic lupus erythematosus, psoriasis covering ≥10% of body surface area, Crohn's disease, ulcerative colitis, or HIV/AIDS).
  • High-sensitivity C-reactive protein (hsCRP) ≥2 mg/L documented in the 12 months preceding the screening visit, and, in absence of any underlying acute or inflammatory conditions.
  • Lipoprotein (a) ≥50 mg/dL or ≥125 nmol/L at any time before the screening visit.
  • Estimated glomerular filtration rate (eGFR) <60 mL/min/1.73 m
  • Ankle branchial index (ABI) <0.9 with no symptoms of intermittent claudication.
  • Metabolic syndrome: increased waist circumference, elevated triglycerides, elevated blood pressure, elevated glucose, and low HDL-C are factors
  • i. Diabetes

排除标准

  • The 10-year ASCVD risk <7.5%.
  • Elevated troponin at baseline.
  • Cognitive impairment.
  • Neurological disorders that would impair their ability to provide informed consent or adhere to study protocols.
  • Metastatic cancer or active cancer undergoing chemotherapy.
  • Terminal illness.
  • Pregnant women or women of childbearing potential not using contraception.
  • Current or past major psychiatric disorders (e.g., schizophrenia, bipolar disorder, severe depression) that could affect physiological or biometric data.
  • Surgical or medical condition, which in the opinion of the Investigator, may place the participant at higher risk from his/her participation in the study, or is likely to prevent the participant from complying with the requirements of the study or completing the study.
  • Unwillingness or inability to comply with study procedures, including adherence to study visits, fasting blood draws and compliance with study protocol.
  • Residing in an inpatient facility or bedbound

结局指标

主要结局

Number of ASCVD events

时间窗: Baseline through 18 months

ASCVD events include myocardial infarction (MI), ischemic stroke/transient ischemic attack (TIA), CV death, or clinically driven arterial revascularization or hospitalization.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Sandra Anping Tsai

Clinical Associate Professor in Medicine

Stanford University

研究点 (1)

Loading locations...

相似试验